Traitements3programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
Losartan (COZZAR®)This study evaluates the pharmacokinetic drug-drug interactions of repeated co-administration of HUC2A-752-A and HUC2A-752-B compared to monotherapy of each agent in healthy adults Hypertension Phase 1 À vérifier South Korea À vérifier
Pitavastatin plus EzetemibeThis study evaluates the pharmacokinetic drug-drug interactions of repeated co-administration of HUC2A-752-A and HUC2A-752-B compared to monotherapy of each agent in healthy adults Hypertension Phase 1 À vérifier South Korea À vérifier
Losartan (COZZAR®)This study evaluates the pharmacokinetic drug-drug interactions of repeated co-administration of HUC2A-752-A and HUC2A-752-B compared to monotherapy of each agent in healthy adults Hypertension Phase 1 À vérifier South Korea À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Losartan (COZZAR®) Hypertension Phase 1 NCT07784621 A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults NOT_YET_RECRUITING

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.